CIMT Endeavour


Event Details


Oslo Cancer Cluster is co-hosting the 4th CIMT Endeavour Workshop on Translating cancer science into products and companies. The Endevaour workshop is a part of the annual CIMT Meeting, which is Europe’s largest immuno-oncology meeting.

The concept of CIMT Endeavour is to organize and build-up a unique and focused education and networking platform that addresses the translation of cancer immunotherapies from preclinical proof of concept to products for patients.

 

CIMT Endeavour 2016 Program

 

08:00 – 08:10       Welcome Address

                      Björn-Philipp Kloke, CIMT

                              

08:10 – 09:00       Session 1: Keynote

                               Lothar Germeroth, Juno Therapeutics

 

09:00 – 10:10       Session 2: From science to products – Change of perspectives

Chair: Andrea Schilz (Ci3), Jutta Heix (Oslo Cancer Cluster)

 

                               CIMT-Scientist Presentation:

10 min + 25 min       Csk overexpression makes T cell dummy

presented by Nadia Mensali, Oslo University Hospital-Radiumhospitalet

 

10 min + 25 min        The HLA-associated phosphoproteome as a new target for immunotherapy against hepatocellular carcinoma

presented by Nico Büttner, Universitätsklinikum Freiburg

                              

                               Expert Advice Panel:

 

                               Stefan Ries, Global Head External Innovation Discovery Oncology, Roche

                               Georg Schnappauf, Patent Lawyer, Zwicker Schnappauf & Partner

                               David Phillips, Partner, SR One Ltd.

 

10:10 – 10:45       Coffee Break

 

10:45 – 11:45       Session 3: Company Story/Successful Deal

Chair: Rainer Wessel, Ci3

 

25 + 5 min                 Corporate Venture Investing in Life Sciences

                               David Phillips, Partner, SR One Ltd

 

25 + 5 min             Precision BioSciences: a 10-Year-Old Startup

                               Derek Jantz, Chairman and CSO, Precision BioSciences, Inc.

 

11:45 – 12:00       Closing Words

                      Cedrik M. Britten, CIMT

 

 

 

 

 

 

Print This Post